AUTHOR=Connolly Laura J. , Rajaratnam Shantha M. W. , Spitz Gershon , Lockley Steven W. , Ponsford Jennie L. 

TITLE=Factors Associated With Response to Pilot Home-Based Light Therapy for Fatigue Following Traumatic Brain Injury and Stroke

JOURNAL=Frontiers in Neurology

VOLUME=12

YEAR=2021

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.651392

DOI=10.3389/fneur.2021.651392

ISSN=1664-2295

ABSTRACT=<p><bold>Background:</bold> Fatigue and sleep disturbance are common and debilitating problems after brain injury. Light therapy shows promise as a potential treatment. We conducted a trial of in-home light therapy to alleviate fatigue and sleep disturbance. The aim of the current study was to identify factors moderating treatment response.</p><p><bold>Methods:</bold> Participants were 24 individuals with traumatic brain injury (TBI) (<italic>n</italic> = 19) or stroke (<italic>n</italic> = 5) reporting clinically significant fatigue. Outcomes included fatigue on Brief Fatigue Inventory (primary outcome), sleep disturbance on Pittsburgh Sleep Quality Index, reaction time (RT) on Psychomotor Vigilance Task and time spent in productive activity. Interactions of demographic and clinical variables with these outcomes were examined in linear mixed-model analyses.</p><p><bold>Results:</bold> Whilst there were no variables found to be significantly associated with change in our primary outcome of fatigue, some variables revealed medium or large effect sizes, including chronotype, eye color, injury severity as measured by PTA, and baseline depressive symptoms. Chronotype significantly moderated sleep quality, with evening chronotype being associated with greater improvement during treatment. Injury type significantly predicted mean RT, with stroke participants exhibiting greater post-treatment reduction than TBI. Age significantly predicted productive activity during Treatment, with younger participants showing stronger Treatment effect.</p><p><bold>Conclusion:</bold> Light therapy may have a greater impact on sleep in younger individuals and those with an evening chronotype. Older individuals may need higher treatment dose to achieve benefit.</p><p><bold>Clinical Trial Registration:</bold><ext-link ext-link-type="uri" xlink:href="http://www.anzctr.org.au" xmlns:xlink="http://www.w3.org/1999/xlink">www.anzctr.org.au</ext-link>, identifier: ACTRN12617000866303.</p>